Nicotine free Feellife Black Tobacco ( Dark Tobacco) E LIQUID from Tobacco Series By Feellife
Concentrated Flavors Black Tobacco ( Dark Tobacco) concentrate
An appreciable concentrate on its own as well as in gourmet recipe, which requires a sufficient maturation time.
This flavor contains tobacco absolute and extract.
Capacity: 10ml,15ml, 30ml, 60ml, 120ml
Nicotine Strength: 0mg/g, 8mg/g, 12mg/g, 18mg/g, 24mg/g
Ingredients: Herbal extract/Glycerol/ Propylene glycol/Flavorings/Nicotine
Bottle type: Child proof cap
Package: top-grade plastic package
Certificates: TUV, MSDS, JRFL, ISO, FDA, GMP, SGS
We produce : Feellife free nicotine Black Devil(Dark Devil) E LIQUID from tobacco series
Feellife 10ml nicotine Black Tobacco ( Dark Tobacco) E LIQUID strength 8mg from tobacco series
Feellife 30ml nicotine Black Tobacco ( Dark Tobacco) E LIQUID strength12mg from tobacco series
Feellife 60ml nicotine Black Tobacco ( Dark Tobacco) E LIQUID strength 16mg from tobacco series
Feellife 30ml nicotine Black Tobacco ( Dark Tobacco) E LIQUID strength 18mg from tobacco series
Feellife 30ml nicotine Black Tobacco ( Dark Tobacco) strength 24mg from tobacco series
We want to create the best Tobacco Series e-Liquids possible. Here is our classic Tobacco Series Range: the finest, premium quality, all-natural and pharmaceutically approved ingredients. This is the reason why we are known worldwide for our first-class products.
All e-Liquids undergo independent quality control and are GCC and TPD compliant, with many international certificates. Our production line uses only high-quality and environmentally friendly ingredients. In order to encompass the best flavours possible, we obtain from raw fruit extracts and genuine tobacco extracts. The ingredients used in our products promote the precise taste and natural elements which is to define our Silver Label flavours.
Feellife uses only high-quality and environment-friendly ingredients that are free of harmful substances.
Made in China
Molecular technology secures natural extracts
High-quality pharmaceutical grade solvents
Natural flavour extracts
Fully TPD Compliant
Huge range of flavours
Since set up in 2009, FEELLiFE has focused on the research and development and production of e-liquid, rapidly developed into the top global e-liquid OEM manufacturer, providing high-quality e-liquid products for many well-known e-liquid brands all over the world.
With modern international standard factory, pharmaceutical grade dust-free workshop and assembly line, FEELLiFE make sure every bottle of e-liquid to meet the requirements of high quality.
Factory Address: 202 North California Ave, City of Industry CA 91744 U.S.A.
Smokers who switch to vaping could be less likely to use cigarettes again, says study
One of the most common new year’s resolutions is to stop smoking. Quite rightly so, considering smoking is the biggest leading, preventable cause of death, worldwide. In fact, tobacco is the only legally available product that kills up to one in every two users, when used as intended.
There are a number of ways to stop smoking. But the most common include going “cold turkey”, the use of medication – usually offered by doctors and stop smoking services – or the switch to e-cigarettes.
There’s little doubt that e-cigarettes, more commonly known as “vapes”, are less harmful than conventional cigarettes. But discussions around exactly how harmful e-cigarettes could be to users and those within close proximity, are still ongoing.
Unlike research conducted into the effects of smoking tobacco, very little is understood about any long-term health effects relating to the use of e-cigarettes. This is mainly due to the fact they are a relatively new product and researchers struggle to study people who use e-cigarettes that have never smoked conventional cigarettes.
Public Health England reports that e-cigarettes are approximately 95 per cent less harmful than conventional cigarettes. However, professor John Newton, Public Health England’s director of health improvement, says: “Our position on the figure is that it is the best available published estimate. It is a useful figure, but it is not a precise scientific estimate.”
Although e-cigarettes do not contain some of the more dangerous components of conventional cigarettes – such as tar or carbon monoxide – some potentially harmful products may be present, including certain heavy metals. The lack of regulation in the industry makes the work of researchers more difficult, as differences between brands can have an impact on any research findings.
Gaps in knowledge
It is estimated that 2.9 million people in the UK regularly use e-cigarettes according to a recent parliamentary report. And in 2016, the tobacco control plan – an initiative from the Department of Health and Social Care which aims to reduce smoking in England – estimated over 470,000 people were using e-cigarettes as a way to stop smoking.
However, the report does not go on to say how many of those using e-cigarettes as an aid to quit smoking achieved this goal. Nor is there yet a true picture of the effects e-cigarettes can have on the small veins and arteries – in both smokers and “second-hand” smokers. These are fundamental knowledge gaps.
I am currently leading a study at Sheffield Hallam University that looks at the benefits and risks of using e-cigarettes to stop smoking. We focus on cardiovascular health, looking at the effect on small veins and arteries.
With funding from Heart Research UK, study participants have their progress monitored over a six-month period. The participants are split into three groups: one using nicotine-rich e-cigarettes, another which is given nicotine-free e-cigarettes, and a third group which is provided with nicotine replacement therapy with the support of Sheffield’s stop smoking services.
All participants receive an identical type of behavioural support to stop smoking, based on the stop smoking services’ support framework. And we are still looking for people to take part in the study. Participants must be willing to give up smoking and be prepared to follow their assigned programme.
Quitting for good
The research team is measuring participants’ cholesterol levels and their nicotine dependence. We are also looking at the amount of carbon monoxide in their breath and assessing the functioning of the small arteries and veins. Results of this mini “checkup” are provided to participants as well.
Preliminary findings show that people who are randomly allocated to the e-cigarette groups are most likely not to take up smoking again and complete their stop smoking attempt, within the study course.
This supports previous work and anecdotal evidence in the field – but to make sure this is definitely the case, we are also dividing participants in each group between those who are successful and those who are not. We are assessing the reasons why the latter group didn’t complete their attempt.
It is hoped that in time, these findings will help to inform new guidelines around the use of e-cigarettes to quit smoking. Importantly, this work will also allow smokers to be given more options and be better informed, so that they can stop smoking for good.
Post time: Jan-21-2019